Management of Thyroiditis
Management of thyroiditis is type-specific: subacute thyroiditis requires beta-blockers and NSAIDs for mild cases or corticosteroids for moderate-to-severe symptoms; painless/postpartum thyroiditis needs only beta-blockers for symptomatic relief (never antithyroid drugs); and amiodarone-induced thyroiditis demands methimazole for type 1 or prednisone for type 2 disease. 1
Subacute Thyroiditis
Initial Approach
For patients presenting with anterior neck pain radiating to ears/jaw, firm tender thyroid on palpation, elevated ESR/CRP, and low radioactive iodine uptake:
- Mild symptoms: Start with beta-adrenergic blockers (for thyrotoxic symptoms) plus NSAIDs (for pain/inflammation) 1
- Moderate-to-severe symptoms or NSAID failure: Initiate corticosteroids 1
- Prednisone 40 mg daily for 2-4 weeks
- Gradual taper over 2-3 months based on clinical response 1
Critical pitfall: Antithyroid drugs have no role here—the thyrotoxicosis results from hormone leakage from destroyed follicles, not new synthesis 1
Hypothyroid Phase Management
- Consider levothyroxine during the hypothyroid phase
- Withdraw after 3-6 months and verify recovery with thyroid function testing 1
- Most patients spontaneously recover normal thyroid function 2, 3
Painless Thyroiditis (Including Postpartum)
Key Management Principles
This autoimmune condition (positive anti-TPO antibodies in most cases) follows a triphasic pattern:
- Thyrotoxic phase: Beta-blockers for symptomatic relief ONLY 1
- Never use antithyroid drugs—new hormone synthesis is already suppressed 1
- Corticosteroids reserved only for severe cases (rarely needed) 1
Postpartum-Specific Considerations
- Occurs within one year of delivery, miscarriage, or medical abortion 3
- Monitor thyroid function throughout the triphasic course
- Levothyroxine may be needed during hypothyroid phase, particularly if TSH >10 mIU/L or TSH 4-10 mIU/L with symptoms or fertility desires 4
- Withdraw levothyroxine after 3-6 months to assess for permanent hypothyroidism 1
Amiodarone-Induced Thyrotoxicosis (AIT)
Type-Specific Treatment Algorithm
Type 1 AIT (increased hormone synthesis):
- Methimazole 40 mg daily until euthyroid (typically 3-6 months) 1
- Split dose if high doses continue to be required 1
Type 2 AIT (destructive thyroiditis):
- Prednisone 40 mg daily for 2-4 weeks 1
- Taper over 2-3 months based on response 1
- Improvement may occur as early as 1 week 1
Indeterminate type or treatment failure:
- Combine methimazole AND prednisone until stabilized 1
- Taper drugs individually once patient stabilizes 1
Refractory Cases
- Thyroidectomy indicated for patients unresponsive to aggressive medical therapy 1
- Counsel patients: surgery carries 9% mortality but delaying surgery has even higher mortality risk 1
- Regional anesthesia preferred when available 1
- Offer surgery before excessive debilitation occurs 1
Important note: Do not routinely discontinue amiodarone—it may control cardiac arrhythmias and has T3-antagonistic cardiac effects; withdrawal may worsen thyrotoxicosis 1
Acute Suppurative Thyroiditis
When destructive thyrotoxicosis occurs (rare):
- Systemic antibiotics plus abscess drainage
- Beta-blockers for symptomatic thyrotoxicosis
- No role for antithyroid drugs 1
Drug-Induced Thyroiditis
Beyond amiodarone, monitor for thyroiditis with:
- Lithium, immune checkpoint inhibitors, interleukin-2, interferon-alfa, tyrosine kinase inhibitors 3
- Management follows painless thyroiditis principles (beta-blockers only, no antithyroid drugs)
Long-Term Surveillance
All thyroiditis types require:
- Serial thyroid function monitoring to detect:
The fundamental distinction in thyroiditis management is recognizing destructive processes (subacute, painless, postpartum, drug-induced) where antithyroid drugs are contraindicated versus true hyperthyroid states requiring hormone synthesis blockade.